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Summary
Aim: Obesity in inflammatory bowel disease (IBD), par-
ticularly Crohn’s disease (CD), has previously been con-
sidered unusual (3%). CD patients who are obese tend to 
have increased perianal complications and a higher level 
of disease activity on an annual basis. Obesity in Scot-
land has been documented to have increased over 
the last decade, and over half all men and women in 
Scotland are now considered to be overweight. This 
study aims to assess obesity prevalence in the IBD com-
munity in Tayside, Scotland. Methods: All IBD patients 
(n = 1,269) were considered for inclusion. Inclusion crite-
ria required a weight measurement taken from the pre-
ceding 12 months and a height measurement within the 
last decade. 489 patients were included in the analysis. 
Results: 18% of the Tayside IBD population were obese 
in comparison to approximately 23% of the Scottish pop-
ulation on a whole. A further 38% of patients were over-
weight, the same percentage as the general population. 
In the overweight and obese ulcerative colitis patients 
there were higher levels of surgery, but the converse 
was true in the CD group, where the normal-weight 
group had the highest levels of surgery. There were sig-
nificantly more obese men and women with CD than 
with ulcerative colitis (P = 0.05). Conclusion: Obesity 
prevalence has increased in IBD patients. This is signifi-
cant because of the known increased levels of postoper-
ative complications, perianal disease and requirement 
for more aggressive medical therapy. Research needs to 
be done to look at the effects of obesity on the co-mor-
bid associations of other diseases with IBD, in particular 
colorectal cancer, and to ascertain whether or not screen-
ing frequency should be altered depending on BMI.
Introduction
Lower BMI has been associated with higher rates of inflam-
matory bowel disease (IBD) in men (P < 0.01) [1]. Obesity 
is traditionally considered unusual in Crohn’s disease (CD), 
but studies of obese patients have linked it to an increase in 
morbidity, with more frequent anoperineal complications and 
increased disease activity on an annual basis [2].
Obesity in Scotland is increasing: 64% of men and 57% 
of women were overweight in 2003, representing an increase 
from 1995 and a greater increase in the obese proportion of 
the population [3]. Previous studies of the juvenile IBD popu-
lation diagnosed between 1963 and 1983 and followed up in 
adult life showed that the CD population had significantly 
lower body weight than people with ulcerative colitis (UC) 
and significantly lower BMI than the general population, 
whereas all UC patients had normal BMIs [4].
The aim of this retrospective study was to assess the distri-
bution of body mass indices in the IBD population of Tayside, 
Scotland.
Material and Methods
The IBD population of Tayside comprises a total of 1,269 patients. To be 
included in the final analysis, the weight obtained from patients’ notes 
had to be taken within the preceding 12 months. In order to avoid inac-
curate BMI measurements, height measurements had to have occurred 
within the preceding decade. Patients over the age of 18 years and aged 
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less than 28, were required to have a height measurement performed dur-
ing that time period in order to be included. The few patients in the adult 
service under the age of 18 had to have both a height and weight measure-
ment in the preceding 12 months in order to be included into the study. 
All weights and heights were obtained by trained professionals on regu-
larly standardised scales and a professionally fitted, wall-mounted height 
measure. Weight measurements were available for all patients, but height 
measurements were not. Patients were excluded if they were known to be 
body builders, pregnant or professional athletes or had undergone bariat-
ric surgery. A total of 489 patients, 194 with UC and 295 with CD, were 
included in the final analysis (38.5% of the total IBD population). The 
1995 WHO Obesity Classification was used to define obesity.
Statistics
Fischer’s exact test was used to assess statistical significance.
Comparison Population
The Scottish population statistics obtained from the most recent national 
census were purchased from the General Register Office for Scotland and 
represent a comparison general population.
Results
Analysis revealed that 18% of the IBD population were 
obese, and there was very little difference in that percentage 
between CD and UC patients (table 1). Comparisons in all 
weight groups between the IBD population and the Scottish 
population were all non-significant.
In the obese group, defined as BMI ≥ 30.0 kg/m2, 19% had 
required surgery for their disease, compared to 18% of those 
being overweight, 46% of those of normal weight, and 10% 
of those who were underweight. These figures were strongly 
influenced by the high level of surgery for patients with CD 
(table 2).
Of the overweight UC patients, 60% were male and 40% 
female, compared to 48% male CD patients and 52% female, 
with the male to female ratio for both groups being not signifi-
cantly different to that of the respective general population. In 
contrast, of the obese UC patients, 56% were male and 44% 
female, compared to 41% male and 59% female CD patients 
showing significant differences for both patient groups (P = 
0.05, 95% CI 0.46–0.66 and 0.31–0.51) when compared with 
the respective general population. Of the total overweight 
IBD patients, 54% were male and 46% female, and of the 
obese IBD patients 47% were male and 53% were female. 
Discussion
The results presented here showed a significant increase in the 
percentage of IBD patients with obesity. In our study, 18% of 
the CD population is obese, and a total of 52% is overweight 
or obese. In contrast, previous studies have reported 3% of 
the CD population as being obese and 32.4% of this popula-
tion with a BMI of 25 kg/m2 or higher [2]. Thus our data sug-
gest a dramatic redistribution in the reported BMI of patients 
with IBD. However, this in line with the increase of obesity in 
the general population.
This increase is of clinical significance because overweight 
CD patients have been found to require surgery earlier in their 
disease course than their underweight counterparts [5], and 
obese patients who undergo ileoanal pouch formation have a 
higher risk of post-operative complications (p = 0.006), includ-
ing wound infection and anastomotic separation [6]. It can be 
expected that this increase in the percentage of overweight or 
obese IBD patients result in higher numbers of surgical inter-
ventions, increased rates of post-operative complications, a 
need for earlier aggressive medical management, and conse-
quently increased costs in management of IBD patients.
Obesity and UC may have inflammatory markers in com-
mon. In a case report on bariatric surgery in an obese UC 
patient [7], it could be shown that the patient’s colitis, possi-
bly due to a reduction in common inflammatory markers, im-
proved after surgery. But further studies supporting this hy-
pothesis are not available thus far. However, bariatric surgery 
has been shown to be potentially curative in other obesity-re-
lated conditions, such as diabetes. More research is necessary 
to elucidate whether or not bariatric surgery is a useful tool in 
the treatment of moderately or severely obese patients with 
active UC.
BMI, kg/m2 Patients with CD Patients with UC Total IBD, % IBD in the general  
Scottish population, %
n % n % 
<18.5   9  3  1  0.5  1 2
18.5–24.9 133 45 74 38 43 38
25–29.9  99 34 85 44 38 38
30–34.9  36 12 24 12 12 20
35–39.9  16  5  9  5  5 <2
>40   2  1  1  0.5  1 <1
Table 1. BMI in IBD 
patients in Tayside
Table 2. Percentage of patients who have had surgery for their IBD
UC patients CD patients Total
Underweight 0 11 10
Normal 5 34 46
Overweight 9 26 18
Obese 3 29 19
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The aetiology of IBD is multifactorial and still poorly un-
derstood. Dietary factors have been assessed as an aetiologi-
cal factor, and, as described several decades ago, a diet higher 
in refined sugar and low in fibre, fruit and vegetables is ac-
companied by an increased incidence of IBD [8, 9]. However, 
despite the dramatic increase in obesity in a western IBD 
population, widespread increases in the incidence of CD have 
not been reported. This suggests that the role of diet in IBD 
needs to be re-examined and assessed. Dietary factors need 
to be linked to gut microbiota, which has been identified as a 
potential aetiological factor in both IBD and, more recently, 
obesity. Such research may allow the development of new 
probiotic and synbiotic strategies for the management of these 
conditions both separately and in combination.
The increase of obesity in the general population is mir-
rored in the IBD subgroup. This result was unexpected as 
traditionally malnutrition and a reduced BMI have been cor-
nerstones in the clinical assessment of IBD and also played a 
significant role in the gold standard for CD assessment, the 
Crohn’s Disease Activity Index [10]. However, when con-
sidering the data presented here demonstrating widespread 
obesity amongst the IBD population, BMI itself can no longer 
be considered an accurate parameter for IBD assessment, and 
focus must shift away from it as it may lead to an underesti-
mation of disease activity and an unwitting exclusion of obese 
IBD patients from clinical trials. 
Currently there is no evidence that obesity in CD signifi-
cantly alters the long-term course of the disease [2, 5]. IBD is 
also associated with increased rates of other diseases such as 
ischaemic heart disease, respiratory disorders, liver disorders, 
strokes, and diabetes. Obesity is also independently associ-
ated with a number of diseases that that have been shown 
to have also associations with IBD [11, 12]. IBD patients are 
screened for colon cancer because of the increased risk [11], 
and cross-sectional studies have linked increased BMI to an 
increased prevalence of adenomas [13, 14]. As yet there are 
no studies dealing with co-morbid disease incidence in the 
obese IBD population. With obesity prevalence in the IBD 
population reflecting that of the general population and with 
those levels expected to rise, further research into this aspect 
of IBD care is warranted, with a particular focus on colorec-
tal cancer. It may be that screening frequency for colorectal 
cancer could be increased or decreased, depending on disease 
and BMI.
In conclusion, obesity has become commonplace in IBD. 
But, in epidemiological terms, little is known about the po-
tentially large-scale impacts this may have on management, 
cost, complications and co-morbid associations. The needs of 
these patients have been demonstrated to be slightly different 
to those of the non-obese IBD patients. Clinical and epide-
miological research is required to better define obesity as a 
process within IBD and to highlight the differences, in order 
to understand whether or not a subtle shift in the treatment 
approaches and in the timing of currently available manage-
ment strategies is required.
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